ARTICLE SUMMARY:
November's most-read articles: Three very informed takes on the future of medical robotics, a conversation with WashU’s Philip Payne, a pioneer in integrating data science into healthcare systems, BSX/Truveta's data sharing partnership, the use of AI in electrophysiology, and GT Medical’s implantable radiotherapy for brain tumors.
The top five MedTech Strategist November articles.
Subscribers, click through to read the full articles. Non-subscribers, take advantage of our free trial offer.
#1: Medical Robotics: Three Perspectives
The opportunity in robotics looks different depending on whether you are building on a leadership position, launching a start-up, or investing in a company. At this year’s WSGR Medical Device Conference, a panel of three, expressing the views and describing the experiences of all three situations, weighs in on the current robotics landscape.
#2: Truveta and Boston Scientific Strive for the Ultimate in Data Sharing: Speed, Accuracy, and Privacy
The data aggregator Truveta and Boston Scientific have embarked on a partnership that tests how advances in healthcare system data sharing can lead to more nuanced insights into patient outcomes, as well as unprecedented information on the comparative effectiveness of specific medical devices and procedures.
#3: Optimizing the Value of Healthcare System Data to Transform Care
Healthcare systems are grappling with the best ways to optimize the value of their data to bring about transformational change in response to relentless challenges. Philip R.O. Payne, one of the nation’s leading biomedical informatics experts, discusses how Washington University School of Medicine in St. Louis/BJC HealthCare is working with collaborators, both internally and externally, to apply its vast data troves to create practical solutions to pressing problems..
#4: GT Medical Technologies: Pioneering a New Paradigm for Brain Tumor Radiotherapy
GT Medical Technologies’ implant delivers radiation therapy directly to the bed of an excised brain tumor—a potential game-changer for people with highly proliferative, hard-to-treat tumors such as glioblastomas. Its GammaTile Therapy is now in use at 75 US hospitals and the firm has raised $26 million over the past three years—not bad for a company that launched its flagship product at the height of the pandemic.
#5: AI for Electrophysiology: Cutting Through the Noise
The use of AI in electrophysiology is increasing; it’s being applied to personalize treatment to achieve better outcomes, to manage patients more effectively, and it’s relieving the burdensome workflow of a data-intensive clinical practice. We interview Implicity and inHEART.
Trial MyStrategist.com and unlock 7-days of exclusive subscriber-only access to the medical device industry's most trusted strategic publications: MedTech Strategist & Market Pathways. For more information on our demographics and current readership click here.
